Axon Stock Falls 18.2% After Q3 Earnings Miss: $130 Million of Dedrone Revenue Slips Beyond Year-End

Axon Enterprise reported third-quarter earnings of $1.72 per share, missing the analyst consensus of $1.89 by $0.17, on revenue of $908.55 million that also came in below the $934.33 million analysts expected. The stock fell 18.2% after the report, as delayed federal drone-defence deployments forced the company to trim its full-year outlook despite revenue still growing 27.8% year over year.

Axon — the maker of Taser devices, body cameras and the Evidence.com software platform — is one of the market's most richly valued defence-technology names, which is exactly why a relatively small miss produced an outsized share-price reaction. The quarter is a clean case study, of the kind regularly dissected on the Zimbuck News page, in how guidance — not the reported numbers alone — drives a growth stock.

The headline numbers

• Adjusted EPS: $1.72 versus $1.89 consensus — a $0.17 miss (FiscalAI figures).
• Revenue: $908.55 million versus $934.33 million expected, up 27.8% year over year.
• Software and services revenue: up 43%, with annual recurring revenue rising 40% to $1.8 billion.
• Year-to-date bookings: up more than 20%.
• Net margin: 6.19%; return on equity: 2.84%.
• Share price reaction: down 18.2% in the session following the report.

The Dedrone problem: $130 million at risk of slipping

The single biggest issue in the quarter was timing, not demand. Delays to three large federal Dedrone deployments — Axon's counter-drone business — put about $130 million of expected revenue at risk of slipping beyond year-end. Management responded by excluding that revenue from fourth-quarter guidance, a conservative step that nonetheless told investors the federal pipeline is lumpier than the market had modelled.

That guidance decision cascaded into the full-year numbers: Axon reduced its 2026 revenue forecast to about $3.6 billion, below the roughly $3.7 billion consensus, and its fourth-quarter revenue guidance also came in under estimates. For a stock priced for flawless execution, "revenue delayed, not lost" is still a reason to mark the shares down first and ask questions later — the debate playing out among stock watchers in the Zimbuck Market News group.

The bull case did not break

Underneath the miss, the franchise metrics remained strong. Software and services growing 43%, ARR compounding at 40% to $1.8 billion, and bookings up more than 20% year to date describe a business still gaining share in public-safety technology. The core story — agencies standardising on Axon's cameras, cloud evidence and now drone defence — was delayed by federal procurement timing, not displaced by a competitor.

If you want a framework for separating a timing miss from a broken story, our guide on how to read an earnings call transcript walks through exactly the language cues — "slipping", "excluded from guidance", "at risk" — that Axon's call was full of.

What to watch from here

Three things decide whether the 18.2% drop was an overreaction or the start of a re-rating. First, any confirmation that the three Dedrone deployments land in early 2027 rather than disappearing. Second, whether software growth can hold near 40% while hardware mix shifts. Third, the valuation reset itself: after a fall of this size, the earnings multiple compresses to a level where merely meeting the lowered $3.6 billion guide may be enough to stabilise the shares.

The balanced reading is that Axon delivered a genuinely disappointing quarter against very high expectations, while its long-term position — recurring software revenue, entrenched agency relationships, a growing counter-drone pipeline — remained intact. That combination usually rewards patience and punishes both panic-selling and blind dip-buying in equal measure.

FAQ

By how much did Axon miss earnings?
EPS of $1.72 missed the $1.89 consensus by $0.17, and revenue of $908.55 million missed the $934.33 million estimate.

Why did the stock fall 18.2% on a small miss?
Because guidance fell with it: about $130 million of Dedrone revenue is at risk of slipping past year-end, and the 2026 revenue forecast was cut to about $3.6 billion.

What grew fastest at Axon this quarter?
Software and services revenue, up 43%, with ARR up 40% to $1.8 billion.

Was any revenue lost permanently?
Management described the Dedrone revenue as delayed and excluded it from Q4 guidance; it did not describe the deployments as cancelled.

What is Axon's net margin?
6.19% for the quarter, with a return on equity of 2.84%.

Source: FiscalAI earnings data as reported by The Lincolnian Online — Axon Enterprise (NASDAQ:AXON) Releases Quarterly Earnings Results, Misses Estimates By $0.17 EPS. This article is market news and general information only, not financial advice. Join the conversation on Zimbuck — the finance social platform for traders and investors.